definiens: means, with respect to a Product, Patent Rights C ontrolled by a Party or any of its Affiliates on or after the Effective Date, includin g any Program Patents, claiming ( a ) the specific co mposition of matter of such Product, ( b ) methods of using such P roduct as a prophylactic or therapeutic or ( c ) the specific method of manufacture of such Product ( unless in th e case of ( c ), such Patent Rights also claim any ot her product or services of [COMPANY] ) ; provided however, Patent Rights Controlled by [COMPANY] or any of its A ffiliates that ( i ) include claims that are directed to subject matter applicab le to ASOs or products in general, or ( ii ) include an ASO, the sequence of which targets the RNA that encodes a Co llaboration Target and the RNA of a gene that does not encode a Collaboration Target ( or similarly, a non- ASO molecule that binds, mimics or otherwise affect s a protein or RNA that is encoded by a [COMPANY] Alternate Modali ty Target and the RNA of a gene that does not encod e a [COMPANY] Alternate Modality Target ), will not be cons idered Product - Specific Patents, and in the case of ( i ) and ( ii ), such Patent Rights will be considered [COMPANY] Core Te chnology Patents